Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12394422rdf:typepubmed:Citationlld:pubmed
pubmed-article:12394422lifeskim:mentionsumls-concept:C0025611lld:lifeskim
pubmed-article:12394422lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:12394422lifeskim:mentionsumls-concept:C0012632lld:lifeskim
pubmed-article:12394422lifeskim:mentionsumls-concept:C0680242lld:lifeskim
pubmed-article:12394422lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:12394422pubmed:issue5-6lld:pubmed
pubmed-article:12394422pubmed:dateCreated2002-10-23lld:pubmed
pubmed-article:12394422pubmed:abstractTextAnimals were trained to discriminate 5 or 10 mg/kg cocaine (rats), or 3 mg/kg (+)-amphetamine (pigeons) from saline, after which dose-response curves were determined for (+)-methamphetamine and other drugs before and after administration of a (+)-methamphetamine-specific monoclonal antibody (K(D) =250 nM). In rats trained to discriminate 10 mg/kg cocaine from saline, intravenous (+)-methamphetamine was about three times more potent as a discriminative stimulus than intraperitoneal (+)-methamphetamine. Also in these rats, intraperitoneal (+)-methamphetamine and (+)-amphetamine were about equipotent as discriminative stimuli, and were about three times more potent than intraperitoneal cocaine. In pigeons trained to discriminate 3 mg/kg intramuscular (i.m.) (+)-amphetamine from saline, (+)-methamphetamine and (+)-amphetamine were nearly equipotent, while cocaine was slightly less potent. In rats trained to discriminate 5 or 10 mg/kg cocaine from saline, intravenous administration of 1 g/kg of the antibody shifted both intravenous and intraperitoneal dose-response curves for (+)-methamphetamine discrimination approximately threefold to the right at 1 or 4 days after administration of the antibody. In pigeons trained to discriminate 3 mg/kg intramuscular (+)-amphetamine from saline, a similar shift of the (+)-methamphetamine dose-response curve to the right also lasted for 4-7 days. However, the antibody did not affect the (+)-amphetamine dose-response curve (pigeons), or the cocaine (rats) dose-response curve. The data show that a low affinity anti-(+)-methamphetamine-specific antibody can produce a specific antagonism of an effect of (+)-methamphetamine that is closely associated with its abuse.lld:pubmed
pubmed-article:12394422pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:languageenglld:pubmed
pubmed-article:12394422pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:citationSubsetIMlld:pubmed
pubmed-article:12394422pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12394422pubmed:statusMEDLINElld:pubmed
pubmed-article:12394422pubmed:monthSeplld:pubmed
pubmed-article:12394422pubmed:issn0955-8810lld:pubmed
pubmed-article:12394422pubmed:authorpubmed-author:McMillanD EDElld:pubmed
pubmed-article:12394422pubmed:authorpubmed-author:HardwickW CWClld:pubmed
pubmed-article:12394422pubmed:authorpubmed-author:OwensS MSMlld:pubmed
pubmed-article:12394422pubmed:authorpubmed-author:LiMiMlld:pubmed
pubmed-article:12394422pubmed:issnTypePrintlld:pubmed
pubmed-article:12394422pubmed:volume13lld:pubmed
pubmed-article:12394422pubmed:ownerNLMlld:pubmed
pubmed-article:12394422pubmed:authorsCompleteYlld:pubmed
pubmed-article:12394422pubmed:pagination465-73lld:pubmed
pubmed-article:12394422pubmed:dateRevised2009-7-7lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:meshHeadingpubmed-meshheading:12394422...lld:pubmed
pubmed-article:12394422pubmed:year2002lld:pubmed
pubmed-article:12394422pubmed:articleTitlePharmacokinetic antagonism of (+)-methamphetamine discrimination by a low-affinity monoclonal anti-methamphetamine antibody.lld:pubmed
pubmed-article:12394422pubmed:affiliationDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, 72205, USA. McMillanDonaldE@uams.edulld:pubmed
pubmed-article:12394422pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12394422pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12394422lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12394422lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12394422lld:pubmed